Global Green, Inc., a scientific research and development company, through its subsidiary, Global Green International, Inc., owns rights to manufacture, distribute, market, and sell a Salmonella antigen and vaccine for poultry industry. The company offer Salmogenics, a poultry salmonella vaccine that is injected in the egg, before it hatches, to give immunity from the Salmonella bacteria to the chick. It intends to sell its products to poultry company veterinarians. The company was formerly known as Global Tech Assets, Inc. and changed its name to Global Green, Inc. in April 2010. Global Green, Inc. was founded in 2004 and is based in Tallahassee, Florida.
Metrics to compare | GOGC | Peers Peers - average of corresponding metrics from companies closely matching GOGC: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGOGCPeersSector |
---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | 0.0x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price / Book | 0.0x | 0.0x | 0.0x | |
Price / LTM Sales | 0.0x | 0.0x | 0.0x | |
Upside (Analyst Target) | 0.0% | 0.0% | 0.0% | |
Fair Value Upside | Unlock | 0.0% | 0.0% | Unlock |